In tumor tissues, the density of CD45RO+ TILs, as well as the combination of CD45RO+ TILs and PD-L1 in tumor areas, significantly correlated with clinicopathological features and prognosis of NSCLC, which can be used as a new prognosis marker. This evidence concerns the gene CD274 and neoplasm.